LRP2 and myeloid sarcoma: Our study did not reproduce the association of MS risk with a CYP27B1 variant, or with exonic variants of VDR. We did detect several variants of interest in LRP2 and CUBN, as well as CYP24A1 and METTL21B variants; these should be confirmed by further studies.